The use of pegIFNα 2a and CD4 cell count ≤350 cells/mL was associated with greater risk of neutropenia while carriers of the SOCS3 rs4969170 AG genotype had significantly lower risk of neutropenia. Here, CD4 is linked to neutropenia.